IRIDEX Goodwill and Intangible Assets 2010-2024 | IRIX
IRIDEX goodwill and intangible assets from 2010 to 2024. Goodwill and intangible assets can be defined as the sum of all intangible asset fields
IRIDEX Annual Goodwill and Intangible Assets
(Millions of US $) |
| 2023 |
$3 |
| 2022 |
$3 |
| 2021 |
$3 |
| 2020 |
$1 |
| 2019 |
$1 |
| 2018 |
$1 |
| 2017 |
$1 |
| 2016 |
$1 |
| 2015 |
$1 |
| 2014 |
$1 |
| 2013 |
$1 |
| 2012 |
$1 |
| 2011 |
$1 |
| 2010 |
$1 |
| 2009 |
$1 |
IRIDEX Quarterly Goodwill and Intangible Assets
(Millions of US $) |
| 2024-09-30 |
$2 |
| 2024-06-30 |
$2 |
| 2024-03-31 |
$3 |
| 2023-12-31 |
$3 |
| 2023-09-30 |
$3 |
| 2023-06-30 |
$3 |
| 2023-03-31 |
$3 |
| 2022-12-31 |
$3 |
| 2022-09-30 |
$3 |
| 2022-06-30 |
$3 |
| 2022-03-31 |
$3 |
| 2021-12-31 |
$3 |
| 2021-09-30 |
$3 |
| 2021-06-30 |
$3 |
| 2021-03-31 |
$3 |
| 2020-12-31 |
$1 |
| 2020-09-30 |
$1 |
| 2020-06-30 |
$1 |
| 2020-03-31 |
$1 |
| 2019-12-31 |
$1 |
| 2019-09-30 |
$1 |
| 2019-06-30 |
$1 |
| 2019-03-31 |
$1 |
| 2018-12-31 |
$1 |
| 2018-09-30 |
$1 |
| 2018-06-30 |
$1 |
| 2018-03-31 |
$1 |
| 2017-12-31 |
$1 |
| 2017-09-30 |
$1 |
| 2017-06-30 |
$1 |
| 2017-03-31 |
$1 |
| 2016-12-31 |
$1 |
| 2016-09-30 |
$1 |
| 2016-06-30 |
$1 |
| 2016-03-31 |
$1 |
| 2015-12-31 |
$1 |
| 2015-09-30 |
$1 |
| 2015-06-30 |
$1 |
| 2015-03-31 |
$1 |
| 2014-12-31 |
$1 |
| 2014-09-30 |
$1 |
| 2014-06-30 |
$1 |
| 2014-03-31 |
$1 |
| 2013-12-31 |
$1 |
| 2013-09-30 |
$1 |
| 2013-06-30 |
$1 |
| 2013-03-31 |
$1 |
| 2012-12-31 |
$1 |
| 2012-09-30 |
$1 |
| 2012-06-30 |
$1 |
| 2012-03-31 |
$1 |
| 2011-12-31 |
$1 |
| 2011-09-30 |
$2 |
| 2011-06-30 |
$2 |
| 2011-03-31 |
$2 |
| 2010-12-31 |
$1 |
| 2010-09-30 |
$2 |
| 2010-06-30 |
$2 |
| 2010-03-31 |
$1 |
| 2009-12-31 |
$1 |
| 2009-09-30 |
$1 |
| 2009-06-30 |
$1 |
| 2009-03-31 |
$1 |
| Sector |
Industry |
Market Cap |
Revenue |
| Computer and Technology |
Laser Systems and Components |
$0.029B |
$0.052B |
|
IRIDEX Corporation is the leading worldwide provider of semiconductor-based laser systems used to treat eye diseases in ophthalmology and skin lesions in dermatology. The products are sold in the United States predominantly through a direct sales force and internationally through independent distributors. The company markets the products using three brand names: IRIS Medical to the ophthalmology market, IRIDERM to the dermatology market, and Light Solutions to the research market.
|
